Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
Phase III
· Site: SITE012 (BRA) (Dr. Kowalski)
· consented 2022-10-21
Adverse events
4
Serious AEs
1
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-01-26 (study day 81); relationship: Y
severe
serious
assessed
2026-08-18
Grade 3 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-02-28 (study day 114); relationship: not assessed; serious criteria: hospitalization
severe
assessed
2026-08-18
Grade 3 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-05-17 (study day 192); relationship: not assessed
mild
assessed
2026-08-18
Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2023-07-15 (study day 251); relationship: not assessed
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.